Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study (Q50913733)

25 March 2018

title

Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study (English)

1 reference

25 March 2018

author

Simon P. Mooijaart

1

1 reference

25 March 2018

Jayne C. Lucke

4

1 reference

25 March 2018

Stella Trompet

3

S Trompet

1 reference

25 March 2018

8

R G J Westendorp

1 reference

25 March 2018

7

J W Jukema

1 reference

25 March 2018

David J Stott

5

D J Stott

1 reference

25 March 2018

Naveed Sattar

2

N Sattar

1 reference

25 March 2018

PROSPER Study Group

10

PROSPER Study Group

1 reference

25 March 2018

author name string

I Ford

6

1 reference

25 March 2018

A J M de Craen

9

1 reference

25 March 2018

language of work or name

English

0 references

publication date

11 March 2013

1 reference

25 March 2018

Journal of Internal Medicine

published in

1 reference

25 March 2018

volume

274

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

77-85

1 reference

25 March 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

cites work

1 reference

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

Interleukin-6 is associated with cognitive function: the Northern Manhattan Study

21 January 2018

1 reference

Systemic markers of inflammation and cognitive decline in old age.

21 January 2018

1 reference

Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study

21 January 2018

1 reference

Genetics of interleukin 6: implications for Alzheimer's disease

21 January 2018

1 reference

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies

21 January 2018

1 reference

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index

21 January 2018

1 reference

Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis

21 January 2018

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Pravastatin and cognitive function in the elderly. Results of the PROSPER study

21 January 2018

1 reference

Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk

21 January 2018

1 reference

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?

21 January 2018

1 reference

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85-plus Study.

21 January 2018

1 reference

Transgenic models to assess the pathogenic actions of cytokines in the central nervous system

21 January 2018

1 reference

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation

21 January 2018

1 reference

C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study

21 January 2018

1 reference

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JOIM.12052

1 reference

25 March 2018

1 reference

25 March 2018